TCMD
insider transactionsTACTILE SYSTEMS TECHNOLOGY INC — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-59.9K
0 buy · 59.9K sell
Net value · 365d
-$1.7M
$0 in · $1.7M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
11
0 buy · 59.9K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
CHIEF FINANCIAL OFFICER
$113.4K
4.6K sh · $24.49
Own -3%
-
Grant·A
Director
$0
6.5K sh
Own +19%
-
Grant·A
Director
$0
6.5K sh
Own +17%
-
Grant·A
Director
$0
6.5K sh
Own +765%
-
Grant·A
Director
$0
6.5K sh
Own +34%
-
Grant·A
Director
$0
6.5K sh
Own +12%
-
Grant·A
Director
$0
6.5K sh
Own +13%
-
Grant·A
Director
$0
852 sh
Own New
-
Sell·S
Chief Executive Officer
$318.1K
11.0K sh · $28.94
Own -4%
-
Sell·S
Sr. VP Mktg & Clinical Affairs
$180.8K
6.2K sh · $28.94
Own -7%
-
Sell·S
CHIEF FINANCIAL OFFICER
$222.9K
7.7K sh · $28.94
Own -5%
-
Sell·S
Chief Executive Officer
$15.4K
537 sh · $28.69
Own -0%
-
Sell·S
Chief Executive Officer
$415.8K
14.7K sh · $28.28
Own -5%
-
Sell·S
Sr. VP Mktg & Clinical Affairs
$4.6K
160 sh · $28.69
Own -0%
-
Sell·S
Sr. VP Mktg & Clinical Affairs
$121.0K
4.3K sh · $28.28
Own -5%
-
Sell·S
CHIEF FINANCIAL OFFICER
$5.6K
196 sh · $28.69
Own -0%
-
Sell·S
CHIEF FINANCIAL OFFICER
$150.5K
5.3K sh · $28.28
Own -4%
-
Grant·A
Chief Executive Officer
$0
28.2K sh
Own +12%
-
Grant·A
Chief Executive Officer
$0
19.8K sh
Own +9%
-
Grant·A
Sr. VP Mktg & Clinical Affairs
$0
7.1K sh
Own +8%
-
Grant·A
Sr. VP Mktg & Clinical Affairs
$0
4.1K sh
Own +5%
-
Grant·A
Sr. VP Mktg & Clinical Affairs
$0
3.5K sh
Own +4%
-
Grant·A
CHIEF FINANCIAL OFFICER
$0
15.6K sh
Own +12%
-
Grant·A
CHIEF FINANCIAL OFFICER
$0
6.8K sh
Own +5%
-
Grant·A
CHIEF FINANCIAL OFFICER
$0
3.6K sh
Own +3%
-
Grant·A
Chief Executive Officer
$0
48.7K sh
Own +28%
-
Grant·A
Sr. VP Mktg & Clinical Affairs · 10b5-1
$0
6.2K sh
Own +9%
-
Grant·A
CHIEF FINANCIAL OFFICER
$0
23.0K sh
Own +23%
-
Sell·S
Sr. VP Mktg & Clinical Affairs · 10b5-1
$148.3K
5.1K sh · $28.85
Own -7%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 11, 2026 | Elaine M. Birkemeyer KEY | Sell S | 4.6K | $113.4K |
| May 6, 2026 | Boyd Vindell Washington | Grant A | 6.5K | $0 |
| May 6, 2026 | Carmen B Volkart | Grant A | 6.5K | $0 |
| May 6, 2026 | Andrea Pearson | Grant A | 6.5K | $0 |
| May 6, 2026 | Laura G. King | Grant A | 6.5K | $0 |
| May 6, 2026 | Raymond Huggenberger | Grant A | 6.5K | $0 |
| May 6, 2026 | Valerie L. Asbury | Grant A | 6.5K | $0 |
| Mar 9, 2026 | Andrea Pearson | Grant A | 852 | $0 |
| Feb 24, 2026 | Sheri Louise Dodd KEY | Sell S | 11.0K | $318.1K |
| Feb 24, 2026 | Kristie Burns | Sell S | 6.2K | $180.8K |
| Feb 24, 2026 | Elaine M. Birkemeyer KEY | Sell S | 7.7K | $222.9K |
| Feb 23, 2026 | Sheri Louise Dodd KEY | Sell S | 537 | $15.4K |
| Feb 23, 2026 | Sheri Louise Dodd KEY | Sell S | 14.7K | $415.8K |
| Feb 23, 2026 | Kristie Burns | Sell S | 160 | $4.6K |
| Feb 23, 2026 | Kristie Burns | Sell S | 4.3K | $121.0K |
| Feb 23, 2026 | Elaine M. Birkemeyer KEY | Sell S | 196 | $5.6K |
| Feb 23, 2026 | Elaine M. Birkemeyer KEY | Sell S | 5.3K | $150.5K |
| Feb 20, 2026 | Sheri Louise Dodd KEY | Grant A | 28.2K | $0 |
| Feb 20, 2026 | Sheri Louise Dodd KEY | Grant A | 19.8K | $0 |
| Feb 20, 2026 | Kristie Burns | Grant A | 7.1K | $0 |
| Feb 20, 2026 | Kristie Burns | Grant A | 4.1K | $0 |
| Feb 20, 2026 | Kristie Burns | Grant A | 3.5K | $0 |
| Feb 20, 2026 | Elaine M. Birkemeyer KEY | Grant A | 15.6K | $0 |
| Feb 20, 2026 | Elaine M. Birkemeyer KEY | Grant A | 6.8K | $0 |
| Feb 20, 2026 | Elaine M. Birkemeyer KEY | Grant A | 3.6K | $0 |
| Feb 19, 2026 | Sheri Louise Dodd KEY | Grant A | 48.7K | $0 |
| Feb 19, 2026 | Kristie Burns 10b5-1 | Grant A | 6.2K | $0 |
| Feb 19, 2026 | Elaine M. Birkemeyer KEY | Grant A | 23.0K | $0 |
| Jan 2, 2026 | Kristie Burns 10b5-1 | Sell S | 5.1K | $148.3K |
About TCMD insider trading
This page tracks insider transactions for TACTILE SYSTEMS TECHNOLOGY INC (TCMD) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.